Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Topoisomerase I-mediated DNA damage.

P Pourquier1, Y Pommier

  • 1Laboratory of Molecular Pharmacology, Division of Basic Sciences, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, USA.

Advances in Cancer Research
|October 18, 2000
PubMed
Summary

Topoisomerase I (Top1) is vital for DNA management and targeted by anticancer drugs. Factors influencing Top1 activity and DNA lesion repair mechanisms are crucial for understanding its biological roles.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mitochondrial topoisomerase I (Top1MT) prevents the onset of metabolic dysfunction-associated steatohepatitis (MASH) in mice.

bioRxiv : the preprint server for biology·2024
Same author

The mitochondrial type IB topoisomerase drives mitochondrial translation and carcinogenesis.

Nature communications·2019
Same author

Development of a Double-Antigen Microsphere Immunoassay for Simultaneous Group and Serotype Detection of Bluetongue Virus Antibodies.

Transboundary and emerging diseases·2016
Same author

BRCA1 haplotype and clinical benefit of trabectedin in soft-tissue sarcoma patients.

British journal of cancer·2015
Same author

DNA damage response pathways and cell cycle checkpoints in colorectal cancer: current concepts and future perspectives for targeted treatment.

Current cancer drug targets·2012
Same author

RNAi screening identifies TAK1 as a potential target for the enhanced efficacy of topoisomerase inhibitors.

Current cancer drug targets·2011

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Genetics

Background:

  • Topoisomerase I (Top1) is an essential enzyme in multicellular organisms, critical for DNA replication, transcription, and chromosome dynamics.
  • Top1's primary role involves relaxing DNA supercoiling, but it also interacts with other proteins, suggesting broader functions.
  • Top1 is a key target for camptothecin anticancer drugs, and its activity can be inhibited by various DNA modifications.

Purpose of the Study:

  • To review factors that modulate Top1 cleavage complexes.
  • To discuss the biological significance of these modulatory effects.
  • To summarize mechanisms for repairing Top1-mediated DNA damage.

Main Methods:

  • Literature review of Topoisomerase I function and regulation.

Related Experiment Videos

  • Analysis of factors affecting Top1 cleavage complex stability.
  • Review of DNA repair pathways for Top1-induced lesions.

    • Main Results:

    • Identified diverse factors that enhance or suppress Top1 cleavage complexes.
    • Highlighted the role of Top1 poisoning in cancer therapy.
    • Summarized known and proposed mechanisms for repairing Top1-mediated DNA lesions.

    Conclusions:

    • Topoisomerase I activity is finely tuned by various cellular and environmental factors.
    • Understanding Top1 modulation and DNA repair is essential for developing targeted therapies and comprehending DNA integrity maintenance.